Albemarle Gains 1.9% to $106.35 Following 17.4% Monthly Basic Materials Drop
Question
Albemarle Gains 1.9% to $106.35 Following 17.4% Monthly Basic Materials Drop
Direct answer
Albemarle advanced 1.9% to $106.35 on October 6, arresting a steep 17.35% monthly drawdown that lagged peers across the Basic Materials complex. The specialty chemicals manufacturer is set to report third-quarter financial figures on November 4, with market attention centered on conversion margins and customer volume off-take commitments.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-07
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Albemarle Gains 1.9% to $106.35 Following 17.4% Monthly Basic Materials Drop”, revision 1, evidence through 2026-10-07. https://marketontology.com/market-events/2026-10-07/albemarle-gains-1-9-to-106-35-following-17-4-monthly-basic-materials-drop-e0157a
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| ALB | battery materials pricing impact on specialty chemical margins | Mixed1-3m | ALB rose 1.9% to $106.35 following a 17.35% monthly decline ahead of Nov 4 earnings. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-13Albemarle Extends Monthly Decline to 13.8% Amid Volatile Chemical Cycle ExpectationsALB LIT
- 2026-10-13Albemarle Falls 13.8% in One Month as Rank Downgrade Tempers Q3 EPS OutlookALB SPY-1.08%
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB CPER-1.95%
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.